DE69631174D1 - Wasserlösliche vitaminzubereitung, zur herstellung ausgezeichneter tabletten undverfahren zu deren herstellung - Google Patents

Wasserlösliche vitaminzubereitung, zur herstellung ausgezeichneter tabletten undverfahren zu deren herstellung

Info

Publication number
DE69631174D1
DE69631174D1 DE69631174T DE69631174T DE69631174D1 DE 69631174 D1 DE69631174 D1 DE 69631174D1 DE 69631174 T DE69631174 T DE 69631174T DE 69631174 T DE69631174 T DE 69631174T DE 69631174 D1 DE69631174 D1 DE 69631174D1
Authority
DE
Germany
Prior art keywords
production
water
pct
soluble vitamin
date mar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69631174T
Other languages
English (en)
Other versions
DE69631174T2 (de
Inventor
Hiroshi Ashida
Daisuke Izutsu
Akio Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of DE69631174D1 publication Critical patent/DE69631174D1/de
Publication of DE69631174T2 publication Critical patent/DE69631174T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69631174T 1996-09-05 1996-10-23 Wasserlösliche vitaminzubereitung, zur herstellung ausgezeichneter tabletten undverfahren zu deren herstellung Expired - Fee Related DE69631174T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23494096A JP4098376B2 (ja) 1996-09-05 1996-09-05 錠剤特性の優れた水溶性ビタミン組成物およびその製造法
JP23494096 1996-09-05
PCT/JP1996/003079 WO1998009624A1 (fr) 1996-09-05 1996-10-23 Composition vitaminique hydrosoluble fournissant de remarquables comprimes et technique de production

Publications (2)

Publication Number Publication Date
DE69631174D1 true DE69631174D1 (de) 2004-01-29
DE69631174T2 DE69631174T2 (de) 2004-09-02

Family

ID=16978662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69631174T Expired - Fee Related DE69631174T2 (de) 1996-09-05 1996-10-23 Wasserlösliche vitaminzubereitung, zur herstellung ausgezeichneter tabletten undverfahren zu deren herstellung

Country Status (12)

Country Link
US (1) US5994324A (de)
EP (1) EP0974355B1 (de)
JP (1) JP4098376B2 (de)
KR (1) KR100441114B1 (de)
CN (1) CN1229356A (de)
AT (1) ATE256462T1 (de)
AU (1) AU7335696A (de)
DE (1) DE69631174T2 (de)
DK (1) DK0974355T3 (de)
ES (1) ES2213182T3 (de)
PT (1) PT974355E (de)
WO (1) WO1998009624A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3419729B2 (ja) * 2000-03-16 2003-06-23 株式会社ファンケル 錠剤およびその製造方法
US6767899B1 (en) * 2000-08-29 2004-07-27 Leiner Health Services Corp. Composition and method for treatment of conditions having an inflammatory component
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
DE60225560T2 (de) * 2001-07-30 2009-04-02 Dsm Ip Assets B.V. Zusammensetzung enthaltend epigallocatechin-gallat
JP3980851B2 (ja) * 2001-08-30 2007-09-26 有限会社ゴトーコーポレーション 固型製剤、その製造方法、及び食品
KR100439979B1 (ko) * 2001-11-06 2004-07-12 샘즈바이오 주식회사 이중 코팅된 순수 비타민-씨 및 그를 함유하는 화장료 조성물과 화장료 조성물 제조방법
CA2470495A1 (en) * 2001-12-24 2003-07-17 Teva Pharmaceutical Industries Ltd. Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
WO2005099681A1 (ja) * 2004-04-14 2005-10-27 Kyowa Hakko Kogyo Co., Ltd. 分岐鎖アミノ酸を含有する錠剤およびその製造方法
CN100431515C (zh) * 2005-05-24 2008-11-12 浙江大学 稳定微粒化药物添加剂的制备方法
FR2898056B1 (fr) 2006-03-01 2012-01-20 Ethypharm Sa Comprimes resistant a l'ecrasement destines a eviter le detournement illicite
WO2008046799A2 (de) * 2006-10-20 2008-04-24 Basf Aktiengesellschaft Preparation of granules of hydrophilic vitamins
JP2010024181A (ja) * 2008-07-18 2010-02-04 Takeda Chem Ind Ltd 固形製剤及びその製造方法
JP5733930B2 (ja) * 2009-09-09 2015-06-10 武田薬品工業株式会社 固形製剤
MX337603B (es) * 2009-11-30 2016-03-10 Adare Pharmaceuticals Inc Composiciones y tabletas farmaceuticas con recubrimiento compresible y metodos de fabricacion.
AU2012222861A1 (en) 2011-02-28 2013-10-17 Monash University Binder powders
CN107772478A (zh) * 2016-08-24 2018-03-09 南京逐陆医药科技有限公司 一种复合维生素片及其制备方法
CN113974171A (zh) * 2021-11-08 2022-01-28 北京素维生物科技有限公司 一种微水快溶组合物、微水快溶食品或药品以及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293132A (en) * 1963-03-25 1966-12-20 Merck & Co Inc Spray dried vitamin compositions and method of preparation
ZA739588B (en) * 1973-01-18 1974-11-27 Hoffmann La Roche Stabilized powder
JPS5114522A (en) * 1974-07-26 1976-02-05 Komatsu Mfg Co Ltd Kakyuenjinno kyufukajihaikishokukaizensochi
NL184308C (nl) * 1975-07-24 1989-06-16 Takeda Chemical Industries Ltd Werkwijze voor het bereiden van l-ascorbienzuurgranules.
JPS58403B2 (ja) * 1975-07-24 1983-01-06 武田薬品工業株式会社 Ｌ− アスコルビンサンセイザイノ セイゾウホウ
DE2706660A1 (de) * 1977-02-17 1978-08-24 Merck Patent Gmbh Ascorbinsaeure enthaltende granulate und verfahren zu ihrer herstellung
JPS5555112A (en) * 1978-10-19 1980-04-22 Sumitomo Chem Co Ltd Preparation of biotin preparation rapidly soluble in water
JPS5749143A (en) * 1980-09-09 1982-03-20 Matsushita Electric Works Ltd Circuit breaker
JPS5759803A (en) * 1980-09-30 1982-04-10 Takeda Chem Ind Ltd Granule of l-sodium ascorbate, its preparation, and tablet comprising it
JPS5879917A (ja) * 1981-11-09 1983-05-13 Showa Denko Kk グリシン錠剤の成形方法
JPS61500435A (ja) * 1983-10-24 1986-03-13 バスフ・コーポレーション 水溶性ビタミンを含有する噴霧乾燥された粉末及びこの方法により製造された粉末
JPH0753663B2 (ja) * 1984-10-09 1995-06-07 武田薬品工業株式会社 チアミン塩の顆粒，その製造法および錠剤
DE3447422A1 (de) * 1984-12-24 1986-06-26 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von ascorbinsaeure-granulat
AU587863B2 (en) * 1985-10-07 1989-08-31 Basf Aktiengesellschaft Vitamin-containing granules and production thereof
JPH0761961B2 (ja) * 1986-06-24 1995-07-05 信越化学工業株式会社 被覆薬剤の製造方法
JPH01165519A (ja) * 1987-12-22 1989-06-29 Ohara Kako Kk 水溶性及び／又は脂溶性ビタミン粒状製剤及びその製造方法
JPH01296953A (ja) * 1988-05-24 1989-11-30 Freunt Ind Co Ltd ビタミンｃ組成物、それを添加した飼料およびその製造方法
JP2880243B2 (ja) * 1989-04-18 1999-04-05 武田薬品工業株式会社 アスコルビン酸カルシウム造粒物
JPH02282323A (ja) * 1989-04-21 1990-11-19 Shin Etsu Chem Co Ltd 徐放性錠剤の製造方法
DE69001003T2 (de) * 1989-08-31 1993-06-17 Takeda Chemical Industries Ltd Vitamin-b12-zusammensetzung.
US5236920A (en) * 1990-04-30 1993-08-17 Basf Corporation Granulated riboflavin product having high flowability, high riboflavin content
US5254551A (en) * 1990-04-30 1993-10-19 Kirk Paula S Flour fortification formulation comprising granulated riboflavin
US5000888A (en) * 1990-05-23 1991-03-19 Basf Corporation Process for spray drying riboflavin to produce a granulate product having low binder content
JP3119801B2 (ja) * 1995-09-28 2000-12-25 武田薬品工業株式会社 ビタミン含有組成物の安定化方法

Also Published As

Publication number Publication date
US5994324A (en) 1999-11-30
KR20000029837A (ko) 2000-05-25
AU7335696A (en) 1998-03-26
WO1998009624A1 (fr) 1998-03-12
JPH1077224A (ja) 1998-03-24
DE69631174T2 (de) 2004-09-02
ATE256462T1 (de) 2004-01-15
EP0974355A1 (de) 2000-01-26
CN1229356A (zh) 1999-09-22
ES2213182T3 (es) 2004-08-16
EP0974355A4 (de) 2000-12-20
PT974355E (pt) 2004-04-30
DK0974355T3 (da) 2004-04-19
KR100441114B1 (ko) 2004-07-19
EP0974355B1 (de) 2003-12-17
JP4098376B2 (ja) 2008-06-11

Similar Documents

Publication Publication Date Title
ATE256462T1 (de) Wasserlösliche vitaminzubereitung, zur herstellung ausgezeichneter tabletten undverfahren zu deren herstellung
MX9806265A (es) TABLETA QUE CONTIENE EL ANTIBIOTICO beta-LACTAMA Y PRODUCCION DE LA MISMA.
EP0372706A3 (de) Verfahren zur Produktion von Akrylat und von Akrylat enthaltendem Polymer
DE59503343D1 (de) Bruch- und lagerstabile, polyfunktionelle reinigungstabletten, verfahren zu ihrer herstellung und ihre verwendung
ATE36699T1 (de) Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung.
ATE147261T1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
KR840005661A (ko) 지속성 매트릭스 정제 조성물의 제조방법
MX9700273A (es) Benzamidinas sustituidas, su preparacion y empleo como sustancias medicamentosas.
EP0360356A3 (de) Verfahren zur Hydrogenierung von funktionalisierten Polymeren und hergestellte Produkte
ES8606906A1 (es) Procedimiento para preparar productos que contienen oligosacaridos a partir de biomasa triturada.
MY102416A (en) Polysaccharide and process for preparing the same
HK1030604A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
ATE216576T1 (de) Vehrfahren zur herstellung von beta-lactam antibiotikum enthaltenden oralen dosisformen
DE3369158D1 (en) Biologically active ws 6049 substances, a process for the production thereof and their pharmaceutical compositions
MY107392A (en) Anti-foaming agent granular and process for producing the same.
NZ503814A (en) Producing composite wood specimen by isostatic pressing with at least 500 bar
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
BG104034A (en) Method for the preparation of pharmaceutical compounds of antidepressive effect and against the parkinson syndrome effect
SE9502941D0 (sv) Förfarande vid framställning av tabletter genom pressning samt tabletter framställda enligt förfarandet
MX9701087A (es) Procedimiento novedoso para la preparacion de diisopinoalcanforilcloroborano.
ATE205473T1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
AP2000001985A0 (en) Novel formulation containing paroxetine.
DE59406461D1 (de) VERFAHREN ZUR HERSTELLUNG VON 8-g(a),12-OXIDO-13,14,15,16-TETRANORLABDAN
AP2000002019A0 (en) Novel formulation containing paroxetine.
JPS6474298A (en) Production of fat as substitute for lanolin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BASF SE, 67063 LUDWIGSHAFEN, DE

8339 Ceased/non-payment of the annual fee